We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Solvent Exposure Poses Health Risk for Pathology Workers

By LabMedica International staff writers
Posted on 07 Jul 2011
Pathologists and laboratory technicians who handle organic solvents such as toluene and xylene are at increased risk of developing autoimmune connective tissue diseases.

A new study showed an occupational health hazard involving solvent use and Raynaud’s phenomenon (RP). More...
Other studies overseas have shown similar solvent associations, but not with people exposed to solvents at work.

“Our study of 341 medical laboratory workers indicates they are more likely to develop a condition called Raynaud’s phenomenon, if they are exposed to solvents such as toluene or xylene. This raises concerns they could then have further serious health complications later in life,” said lead investigator Gordon Purdie, at the department of medicine, University of Otago, (Wellington, New Zealand).

Raynaud’s phenomenon is characterized by vasoconstriction, or the narrowing of blood vessels in the hands and other extremities, and is characterized by pain, color changes, and tautness or fullness of the fingers or toes. For some people it is a symptom or precursor of scleroderma, a rare connective tissue disease affecting multiple systems in the body and mainly among women.

Lab workers who worked with acetone or chlorinated solvents, combined with xylene or toluene, doubled their risk of developing RP. Risk of developing severe RP was even greater, in fact nine times.

The mainly female laboratory workers (79%) who used solvents in this study had higher rates of RP. Those who had worked with xylene or toluene doubled their risk of developing severe RP.

The study was presented at the Australian Rheumatology Association Scientific Meeting in Brisbane (QLD, Australia), which was held from May 14-17, 2011. The study also appeared online in the June 2011 issue of the Journal of Rheumatology.

Related Links:

University of Otago


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.